LinkDoc Technology has reportedly whipped away its plans to IPO in the United States in the wake of the DiDi calamity which continues to come under scrutiny in both the East and West.
The Chinese medical data group has been working on a float, with intentions to raise US$211mln, but according to a Reuters report the IPO has been shelved.
Ride-hailer Didi has been under fire in the market since a Chinese authorities clampdown which saw its app banned in the immediate aftermath of its US$4.4bn IPO and US markets debut.
DiDi shares plummeted this week after the censure.
The Chinese government this weekend said that group had committed serious violations related to the collection and use of personal data, and, ordered its apps be removed from app stores in the country.
Prior to the float, there had been some reports that an antitrust probe could be among the risks associated with the offering and those concerns were described at the time by the company as "unsubstantiated speculation from unnamed sources".